These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17044299)

  • 61. [Approaches for interventional therapy of hepatoma].
    Guan YS; Yang L
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):785. PubMed ID: 16248956
    [No Abstract]   [Full Text] [Related]  

  • 62. [Regional therapy of liver tumors].
    Spangenberg HC; Mohr L; Blum HE
    Internist (Berl); 2007 Jan; 48(1):40-5. PubMed ID: 17160664
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Complete response (CR) in a case of advanced hepatocellular carcinoma by percutaneous multi-ablation therapy].
    Ishihara K; Beppu T; Ishiko T; Iwagami S; Doi K; Hirota M; Yamashita Y; Ogawa M
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1791-4. PubMed ID: 11708036
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Safety assessment and therapeutic efficacy of percutaneous microwave ablation therapy combined with percutaneous ethanol injection for hepatocellular carcinoma adjacent to the gallbladder.
    Huang H; Liang P; Yu XL; Cheng ZG; Han ZY; Yu J; Liu FY
    Int J Hyperthermia; 2015 Feb; 31(1):40-7. PubMed ID: 25766386
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation.
    Shiina S; Teratani T; Obi S; Hamamura K; Koike Y; Omata M
    Oncology; 2002; 62 Suppl 1():64-8. PubMed ID: 11868788
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Laparoscopic US-guided percutaneous ethanol ablation of hepatocellular carcinoma.
    Mehta M; Asch MR; Gallinger S
    J Vasc Interv Radiol; 1998; 9(4):583-7. PubMed ID: 9684827
    [No Abstract]   [Full Text] [Related]  

  • 67. [Percutaneous ablation of hepatocellular carcinoma in older patients in clinical practice].
    Romero Gutiérrez M; Ruano Díaz L; Muñoz López D; Artaza Varasa T; González de Frutos C; Sánchez Ruano JJ; de la Cruz Pérez G; Gómez Rodríguez R
    Gastroenterol Hepatol; 2015 Feb; 38(2):54-61. PubMed ID: 25499846
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Locoregional therapy of hepatocellular carcinoma.
    Habib A; Desai K; Hickey R; Thornburg B; Lewandowski R; Salem R
    Clin Liver Dis; 2015 May; 19(2):401-20. PubMed ID: 25921670
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma.
    Allgaier HP; Deibert P; Zuber I; Olschewski M; Blum HE
    Lancet; 1999 May; 353(9165):1676-7. PubMed ID: 10335793
    [No Abstract]   [Full Text] [Related]  

  • 70. [Recurrence of hepatocellular carcinoma associated with hepatitis C virus after tumor ablation].
    Sakaguchi K; Kobayashi Y; Matsumoto E; Shiratori Y
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):629-33. PubMed ID: 15359874
    [No Abstract]   [Full Text] [Related]  

  • 71. [Diagnosis and multimodal therapy for hepatocellular carcinoma].
    Kolligs FT; Hoffmann RT; op den Winkel M; Bruns CJ; Herrmann K; Jakobs TF; Lamerz R; Trumm C; Zech CJ; Wilkowski R; Graeb C
    Z Gastroenterol; 2010 Feb; 48(2):274-88. PubMed ID: 20119895
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Percutaneous radiofrequency thermal ablation for liver tumours.
    Jiao LR
    Lancet; 1999 Jul; 354(9176):427-8. PubMed ID: 10437901
    [No Abstract]   [Full Text] [Related]  

  • 73. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma].
    Xu ZM; Wang JH; Zhen ZJ; Chen HW; Cui WZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1626-8. PubMed ID: 17121718
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma.
    Lencioni R; Crocetti L
    Clin Liver Dis; 2005 May; 9(2):301-14, viii. PubMed ID: 15831275
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas.
    Ohmoto K; Yamamoto S
    Clin Radiol; 2006 Sep; 61(9):800-1; author reply 801-2. PubMed ID: 16905390
    [No Abstract]   [Full Text] [Related]  

  • 76. The role of focal liver ablation in the treatment of unresectable primary and secondary malignant liver tumors.
    Gannon CJ; Curley SA
    Semin Radiat Oncol; 2005 Oct; 15(4):265-72. PubMed ID: 16183480
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Percutaneous ablation therapy for hepatocellular carcinoma: current practice and future perspectives.
    Huo TI; Huang YH; Wu JC
    J Chin Med Assoc; 2005 Apr; 68(4):155-9. PubMed ID: 15850062
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [The combination of percutaneous iohexol-ethanol injection with radiofrequency ablation for the treatment of primary liver cancer in high-risk locations].
    Sun W; Ding XY; Chen JL; Li WD; Wang XY; Guo XD; Shen YJ; Sun SS
    Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):695-700. PubMed ID: 28926900
    [No Abstract]   [Full Text] [Related]  

  • 79. Hemolysis as a complication of radiofrequency ablation for hepatocellular carcinoma must be paid more attention.
    Li H; Li B; Wei Y; Liu F
    Dig Dis Sci; 2011 Nov; 56(11):3391-2. PubMed ID: 21567191
    [No Abstract]   [Full Text] [Related]  

  • 80. [Clinical effects of local hyperthermia in patients with advanced hepatocellular carcinoma].
    Fukuda Y
    Nihon Shokakibyo Gakkai Zasshi; 1985 Feb; 82(2):336. PubMed ID: 2987581
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.